{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:52:10Z","timestamp":1789656730583,"version":"4.0.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Bipolar disorder (BD) is a chronic and disabling affective disorder with significant morbidity and mortality. Despite the high rate of psychiatric and physical health comorbidity, little is known about the complex interrelationships between clinical features of bipolar illness and comorbid conditions. The present study sought to examine, quantify and characterize the cross-sectional associations of psychiatric and physical comorbidities with selected demographic and clinical characteristics of adults with BD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A nationwide multicenter cross-sectional observational epidemiological study conducted from October 2015 to March 2017 in Slovakia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 179 study participants [median age 49\u2009years (interquartile range IQR 38\u201358); 57.5% females], 22.4% were free of comorbidity, 42.5% had both psychiatric and physical comorbidities, 53.6% at least one psychiatric comorbidity, and 66.5% at least one physical comorbidity. The most prevalent were the essential hypertension (33.5%), various psychoactive substance-related disorders (21.2%), specific personality disorders (14.6%), obesity (14.5%), and disorders of lipoprotein metabolism (14%). The presence of an at least one physical comorbidity, atypical symptoms of BD, and unemployed status were each associated with an at least one psychiatric comorbidity independent of sex, early onset of BD (age of onset &amp;lt;35\u2009years), BD duration and pattern of BD illness progression (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). The presence of various psychoactive substance-related disorders, BD duration, atypical symptoms of BD, unemployed status, pension, female sex, and not using antipsychotics were each associated with an at least one physical comorbidity independent of the pattern of BD illness progression (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). In several other multiple regression models, the use of antipsychotics (in particular, olanzapine) was associated with a decreased probability of the essential hypertension and predicted the clinical phenotype of comorbidity-free BD (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This cross-national study has reported novel estimates and clinical correlates related to both the comorbidity-free phenotype and the factors associated with psychiatric and physical comorbidities in adults with BD in Slovakia. The findings provide new insights into understanding of the clinical presentation of BD that can inform clinical practice and further research to continue to investigate potential mechanisms of BD adverse outcomes and disease complications onset.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2023.1208551","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T16:27:00Z","timestamp":1690302420000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Factors associated with psychiatric and physical comorbidities in bipolar disorder: a nationwide multicenter cross-sectional observational study"],"prefix":"10.3389","volume":"14","author":[{"given":"Jozef","family":"Dragasek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Minar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pallayova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"ref2","year":"2022"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","article-title":"Bipolar disorder prevalence: a systematic review and meta-analysis of the literature","volume":"37","author":"Clemente","year":"1999","journal-title":"Rev Brasileira Psiquiatria"},{"key":"ref4","year":"2019"},{"key":"ref5","year":"2023"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/bdi.13016","article-title":"Bipolar disorder: Trimodal age-at-onset distribution","volume":"23","author":"Bolton","year":"2021","journal-title":"Bipolar Disord"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/acps.13490","article-title":"A systematic review and meta-analysis of delayed help-seeking, delayed diagnosis and duration of untreated illness in bipolar disorders","volume":"146","author":"Scott","year":"2022","journal-title":"Acta Psychiatr Scand"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1176\/appi.ajp.158.3.420","article-title":"Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder","volume":"158","author":"McElroy","year":"2001","journal-title":"Am J Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jad.2022.12.023","article-title":"Cardiometabolic and endocrine comorbidities in women with bipolar disorder: a systematic review","volume":"323","author":"Pahwa","year":"2023","journal-title":"J Affect Disord"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a Swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1176\/ps.2006.57.8.1140","article-title":"Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization","volume":"57","author":"McIntyre","year":"2006","journal-title":"Psychiatric Ser"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jad.2023.01.083","article-title":"Physical health comorbidities in older adults with bipolar disorder: a systematic review","volume":"326","author":"Warner","year":"2023","journal-title":"J Affect Disord"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/add.15680","article-title":"Genome-wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci","volume":"117","author":"Wistr\u00f6m","year":"2022","journal-title":"Addiction"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"110688","DOI":"10.1016\/j.pnpbp.2022.110688","article-title":"Integrative analysis to identify shared mechanisms between schizophrenia and bipolar disorder and their comorbidities","volume":"122","author":"Bharadhwaj","year":"2023","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"14450","DOI":"10.1038\/s41598-021-93653-3","article-title":"A system biology approach based on metabolic biomarkers and protein-protein interactions for identifying pathways underlying schizophrenia and bipolar disorder","volume":"11","author":"Altaf-Ul-Amin","year":"2021","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"key":"ref17","year":"2016"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/j.1541-0420.2011.01619.x","article-title":"A new criterion for confounder selection","volume":"67","author":"VanderWeele","year":"2011","journal-title":"Biometrics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.4088\/JCP.14r09635","article-title":"Prevalence and predictors of type 2 diabetes mellitus in people with bipolar disorder: a systematic review and meta-analysis","volume":"76","author":"Vancampfort","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00125-021-05609-x","article-title":"Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews","volume":"65","author":"Lindekilde","year":"2022","journal-title":"Diabetologia"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"101013","DOI":"10.1016\/j.yfrne.2022.101013","article-title":"Appetite-regulating hormones in bipolar disorder: a systematic review and meta-analysis","volume":"67","author":"Misiak","year":"2022","journal-title":"Front Neuroendocrinol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neubiorev.2021.11.026","article-title":"Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review","volume":"132","author":"Gim\u00e9nez-Palomo","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1038\/tp.2016.261","article-title":"The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies","volume":"7","author":"Amare","year":"2017","journal-title":"Transl Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/schbul\/sbab087","article-title":"Antipsychotics use is associated with greater adherence to cardiometabolic medications in patients with schizophrenia: results from a Nationwide, within-subject design study","volume":"48","author":"Solmi","year":"2022","journal-title":"Schizophr Bull"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.sjpain.2015.12.002","article-title":"Migraine headache and bipolar disorder comorbidity: a systematic review of the literature and clinical implications","volume":"11","author":"Leo","year":"2016","journal-title":"Scand J Pain"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00115-013-3766-z","article-title":"Side effects and risk profile of lithium: critical assessment of a systematic review and meta-analysis","volume":"84","author":"Bschor","year":"2013","journal-title":"Nervenarzt"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jad.2016.01.040","article-title":"The prevalence and predictors of bipolar and borderline personality disorders comorbidity: systematic review and meta-analysis","volume":"195","author":"Fornaro","year":"2016","journal-title":"J Affect Disord"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jad.2016.05.048","article-title":"Comorbidity between bipolar disorder and borderline personality disorder: prevalence, explanatory theories, and clinical impact","volume":"202","author":"Fr\u00edas","year":"2016","journal-title":"J Affect Disord"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S2215-0366(15)00112-1","article-title":"Lifetime prevalence of anxiety disorders in people with bipolar disorder: a systematic review and meta-analysis","volume":"2","author":"Pavlova","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/070674370705200309","article-title":"Anxiety comorbidity and quality of life in bipolar disorder patients","volume":"52","author":"Kauer-Sant'Anna","year":"2007","journal-title":"Can J Psychiatr"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5498\/wjp.v9.i1.7","article-title":"Comorbidity of bipolar and anxiety disorders: an overview of trends in research","volume":"9","author":"Spoorthy","year":"2019","journal-title":"World J Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1192\/bjp.184.6.496","article-title":"Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder","volume":"184","author":"Watson","year":"2004","journal-title":"Br J Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1007\/s40618-021-01600-w","article-title":"Role of thyroid hormone therapy in depressive disorders","volume":"44","author":"Bauer","year":"2021","journal-title":"J Endocrinol Investig"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"546801","DOI":"10.3389\/fpsyt.2021.546801","article-title":"The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment","volume":"12","author":"Gim\u00e9nez-Palomo","year":"2021","journal-title":"Front Psychol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/408136","article-title":"The potential role of the NLRP3 Inflammasome as a link between mitochondrial complex I dysfunction and inflammation in bipolar disorder","volume":"2015","author":"Kim","year":"2015","journal-title":"Neural Plast"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jad.2015.08.058","article-title":"Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications","volume":"188","author":"Rosenblat","year":"2015","journal-title":"J Affect Disord"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1054\/plef.1999.0037","article-title":"Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes","volume":"60","author":"Horrobin","year":"1999","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.pnpbp.2010.02.027","article-title":"Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during a first manic episode","volume":"34","author":"Salvadore","year":"2010","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ajmg.b.30498","article-title":"Increase in GSK3beta gene copy number variation in bipolar disorder","author":"Lachman","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/aap.12019","article-title":"Noradrenaline transmission reducing drugs may protect against a broad range of diseases","volume":"34","author":"Fitzgerald","year":"2015","journal-title":"Auton Autacoid Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1399-5618.2005.00182.x","article-title":"Clinical correlates of current level of functioning in primary care-treated bipolar patients","volume":"7","author":"Hajek","year":"2005","journal-title":"Bipolar Disord"},{"key":"ref42","year":"2023"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1399-5618.2004.00138.x","article-title":"Burden of general medical conditions among individuals with bipolar disorder","volume":"6","author":"Kilbourne","year":"2004","journal-title":"Bipolar Disord"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jpsychires.2007.10.009","article-title":"Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder","volume":"42","author":"Soreca","year":"2008","journal-title":"J Psychiatr Res"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2174\/1570159X14666160902145635","article-title":"Is mania the hypertension of the mood? Discussion of a hypothesis","volume":"15","author":"Rihmer","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jad.2021.10.101","article-title":"Assessment of the relationships between genetic determinants of thyroid functions and bipolar disorder: a mendelian randomization study","volume":"298","author":"Chen","year":"2022","journal-title":"J Affect Disord"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1065754","DOI":"10.3389\/fpsyt.2022.1065754","article-title":"Circadian rhythm disruptions: a possible link of bipolar disorder and endocrine comorbidities","volume":"13","author":"Yan","year":"2022","journal-title":"Front Psychol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/00048674221106669","article-title":"Clinical correlates of comorbid attention deficit hyperactivity disorder in adults suffering from bipolar disorder: a meta-analysis","volume":"57","author":"Bartoli","year":"2023","journal-title":"Aust N Z J Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S2215-0366(15)00544-1","article-title":"Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis","volume":"3","author":"Agnew-Blais","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bdi.12419","article-title":"Is age of onset associated with severity, prognosis, and clinical features in bipolar disorder? A meta-analytic review","volume":"18","author":"Joslyn","year":"2016","journal-title":"Bipolar Disord"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.comppsych.2015.01.004","article-title":"Co-morbidity of bipolar disorder and borderline personality disorder: findings from the National Epidemiologic Survey on alcohol and related conditions","volume":"58","author":"McDermid","year":"2015","journal-title":"Compr Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.neubiorev.2019.09.025","article-title":"Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders","volume":"107","author":"Morris","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.31887\/DCNS.2018.20.1\/mdehert","article-title":"The intriguing relationship between coronary heart disease and mental disorders","volume":"20","author":"De Hert","year":"2018","journal-title":"Dialogues Clin Neurosci"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neubiorev.2018.01.010","article-title":"Metabolic\/inflammatory\/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target","volume":"87","author":"Swardfager","year":"2018","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1208551\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T16:27:04Z","timestamp":1690302424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2023.1208551\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":54,"alternative-id":["10.3389\/fpsyt.2023.1208551"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2023.1208551","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"article-number":"1208551"}}